Could I have , please? http://myvidster.fun/ myvidster.com The Swiss group has also benefited from setbacks atpotential challengers. On Thursday, Teva and Lonza said they were discontinuing a venture to developso-called "biosimilars," the latest competitor to halt or delayprojects due to high costs and complications.